We report results of first-principles calculations based on the projector augmented wave
(PAW) method to explore the structural, thermodynamic, and electronic properties of cubic …

CLIN AND EXP RHEUM 25/6 Page 1 Clinical and Experimental Rheumatology 2007; 25:
810-816. A multicenter study of leukocytapheresis in rheumatoid arthritis Y. Ueki1, A. Sagawa2 …

To evaluate the efficacy of high-dose leukocytapheresis (LCAP) using a large filter in
patients with refractory rheumatoid arthritis (RA), we conducted a multicenter …

Rheumatoid arthritis (RA) is a systemic inflammatory disease in which the predominant
symptom is polyarthritis that follows a chronic and progressive clinical course characterized …

Infliximab (INF), a tumor necrosis factor‐alpha (TNF‐α) inhibitor, is an effective drug for
patients with rheumatoid arthritis (RA). However, some patients receive no clinical benefit, or …

This is the first report on the efficacy of leukocytapheresis (LCAP) in a patient with refractory
systemic-type adult-onset Still's disease (AOSD). A 17-year-old Japanese woman with …

The objective of this study is to evaluate the cellular mechanism underlying filtration
leukocytapheresis (LCAP) therapy for the treatment of rheumatoid arthritis (RA). Thirteen …

This is the first report on effective leukocytapheresis (LCAP) in an acquired infliximab (IFM)
resistant patient with rheumatoid arthritis (RA). A 44-year-old Japanese woman with RA was …

During the development of autoimmune and inflammatory diseases, infiltration by multiple
leukocyte types is commonly observed at the site of inflammation. These cells are …

We report the case of a 44-year-old female undergoing maintenance hemodialysis in whom
early-phase rheumatoid arthritis (RA) was successfully treated by leukocytapheresis (LCAP) …